Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00156988
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : August 10, 2009
Sponsor:
Collaborator:
Dutch Burns Foundation
Information provided by:
Association of Dutch Burn Centres

Brief Summary:
The objective of the proposed study is to assess whether the application of flammacerium for 2 days is as good as, or even better than, the application of flammacerium for 10 days regarding woundhealing in partial thickness burns.

Condition or disease Intervention/treatment Phase
Burns Drug: cerium nitrate-silver sulfadiazine (cerium-flamazine) Phase 4

Detailed Description:
Cerium is suggested to halt the cytokine cascade ensuing burn injury by binding the 'burn toxin' and, when used in combination with silver-sulfadiazine, may enhance its antibacterial effect. Since 1984, the combination of cerium and silver sulfadiazine, flammacerium, has been used in our centre. Current practice is to treat acute, non-facial, burns with daily cleaning and (re-)application of flammacerium for a total of ten days. However, prolonged application of cerium is thought to be unnecessary - it is effective in the early stages after injury- and prolonged application of silver sulfadiazine has a negative effect on wound healing. The objective of the proposed study is therefore, to assess whether the application of flammacerium for 2 days is as good as, or even better than, the application of flammacerium for 10 days regarding woundhealing in partial thickness burns.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Study Start Date : March 2004
Study Completion Date : December 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Burns




Primary Outcome Measures :
  1. number of days required for wound healing, judged clinically and assessed as both number of days till 95% and 100% re-epithelialisation by planimetry at the time the decision regarding surgery is made (8-10 pb) and as wounds are considered healed

Secondary Outcome Measures :
  1. Wound colonisation, assessed by swabs taken at 0 or 3 days pb, 7 days pb and subsequently every 7 days until wounds are healed or treated surgically, and on indication


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients having partial thickness burns with TBSA of < 10%

Exclusion Criteria:

  • patients not seen within 24 hours postburn
  • patients with only facial burns
  • patients with electrical or chemical burns
  • patients or their parents/caregivers with mental or cognitive deficits that may interfere with providing informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00156988


Locations
Layout table for location information
Netherlands
Burns Centre, Martini Hospital
Groningen, Netherlands, 9728NZ
Sponsors and Collaborators
Association of Dutch Burn Centres
Dutch Burns Foundation
Investigators
Layout table for investigator information
Principal Investigator: Marianne K Nieuwenhuis, PhD Association Dutch Burns Centres
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00156988    
Other Study ID Numbers: WO/P04.103
WO/P04.103
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: August 10, 2009
Last Verified: August 2009
Keywords provided by Association of Dutch Burn Centres:
burns
partial thickness
cerium flamazine
randomised clinical trial
Additional relevant MeSH terms:
Layout table for MeSH terms
Burns
Wounds and Injuries
Sulfadiazine
Silver Sulfadiazine
Cerium nitrate
Anti-Bacterial Agents
Anti-Infective Agents
Antiprotozoal Agents
Antiparasitic Agents
Coccidiostats
Anti-Infective Agents, Local